The HD_N171(TT);HQ-021 targeted mutation has the N171 HTT transgene (human huntingtin fragment encoding the first 171 amino acids with 145 mixed CAA-CAG repeats) inserted into the mouse Gt(ROSA)26Sor locus. The polyQ repeat assay shows heterozygous mice over several generations have a stable 141 polyQ repeat. These mice are part of a series expressing different human HTT amino acid length fragments, and may be useful for studying comparable patterns and levels of HTT expression in Huntington's disease.
Dr. David Howland, CHDI Foundation
Brenda Lager, CHDI Foundation
Laragen Sequencing and Genotyping, Laragen, Inc
Stephani Dempsey, The Jackson Laboratory
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Inserted expressed sequence, RMCE-ready) | Gt(ROSA)26Sor | gene trap ROSA 26, Philippe Soriano |
Stock No. 027426 was formerly associated with CHDI Foundation colony Stock No. 370308 [CHDI-81002021].
Huntington's disease (HD) is an autosomally dominant, fatal neurodegenerative disorder characterized by uncontrolled movements, psychiatric disturbances and cognitive impairment. HD is caused by an unstable trinucleotide (polyglutamine) repeat expansion in the huntingtin gene (HTT; HD or Hdh).
The HD_N171(TT);HQ-021 targeted mutation has the CMV early enhancer/chicken beta actin promoter driving expression of the N171 HTT transgene (human HTT fragment encoding the first 171 amino acids with 145 mixed CAA-CAG repeats [see polyQ assay note below]) from the mouse Gt(ROSA)26Sor locus. Heterozygous mice are expected to be viable and fertile. The phenotype of these mice is not further characterized to date (August 2015).
Important note on polyQ assay: over several generations, the polyQ repeat assay shows heterozygous mice have maintained a stable 141 polyQ repeat length.
This Huntington's disease mouse model is available by way of a collaborative effort between CHDI Foundation, Taconic Artemis and The Jackson Laboratory.
These mice are part of a series expressing different human HTT amino acid length fragments from Gt(ROSA)26Sor. All are reported to have a stable array of 145 mixed CAA-CAG repeats (see polyQ assay note above) and are on the C57BL/6 genetic background. Together, they are useful in studying comparable patterns and levels of HTT expression. The series includes:
HD_N171(TT);HQ-021 mice are Stock No. 027426
HD_A463(TT);HQ-020 mice are Stock No. 027427
HD_DS536(TT);HQ-019 mice are Stock No. 027428
HD_D552(TT);HQ-017 mice are Stock No. 027429
HD_D586(TT);HQ-016 mice are Stock No. 027430
HD_1000aa(TT);HQ-022 mice are Stock No. 027431
The HD_N171(TT);HQ-021 targeted mutation was designed by Taconic Artemis to have the CMV early enhancer/chicken beta actin promoter sequence and the N171 HTT transgene all inserted into the mouse Gt(ROSA)26Sor locus on chromosome 6. The N171 HTT sequence has a human huntingtin [HTT] fragment encoding the first 171 amino acids (with 145 mixed CAA-CAG repeats [see polyQ assay note below]). Mice were sent to the CHDI Foundation colony as Stock No. 370308 [CHDI-81002021]. The colony is reported to be on the C57BL/6 genetic background. In 2015, animals were sent from the CHDI Foundation colony to The Jackson Laboratory Repository, from which B6.HD_N171(TT);HQ-021 heterozygotes are available as Stock No. 027426.
Important note on polyQ assay: over several generations, the polyQ repeat assay shows heterozygous mice have maintained a stable 141 polyQ repeat length.
In 2016, a 32 SNP (single nucleotide polymorphism) panel analysis, with 27 markers covering all 19 chromosomes and the X chromosome, as well as 5 markers that distinguish between the C57BL/6J and C57BL/6N substrains, was performed on the first generation rederived living colony at The Jackson Laboratory Repository. While the 27 markers throughout the genome were all found to be C57BL/6 allele-type, 3 of 5 markers that determine C57BL/6J from C57BL/6N were found to be segregating in some mice (chromosomes 8 [~15.2 Mbp], 11 [~4.4 Mbp], 13 [~41.0 Mbp], 15 [~57.6 Mbp] and 19 [~49.9 Mbp]). These data suggest that the mice sent to The Jackson Laboratory Repository colony were on a mixed C57BL/6J;C57BL/6N genetic background.
Allele Name | targeted mutation 51, TaconicArtemis |
---|---|
Allele Type | Targeted (Inserted expressed sequence, RMCE-ready) |
Allele Synonym(s) | N171-Q148 |
Gene Symbol and Name | Gt(ROSA)26Sor, gene trap ROSA 26, Philippe Soriano |
Gene Synonym(s) | |
Strain of Origin | Not Specified |
Chromosome | 6 |
Molecular Note | A cDNA construct carrying mutant Huntington gene (145Q) truncated at position aa N171 under the control of the CMV early enhancer/chicken beta actin promoter was targeted into Gt(ROSA)26Sor locus by RMCE. |
When maintaining a live colony, heterozygous mice may be bred to wildtype mice from the colony or to C57BL/6J inbred mice (Stock No. 000664). To date (August 2015), it has not been attempted to make this strain homozygous.
When using the B6.HD_N171(TT);HQ-021 ; HQ0021-HD_N171(TT) on a B6 background ; CHDI-81002021 mouse strain in a publication, please cite the originating article(s) and include JAX stock #027426 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous or wildtype for Gt(ROSA)26Sor<tm51(HTT)Arte> |
Frozen Mouse Embryo | B6.Cg-Gt(ROSA)26Sor<tm51(HTT)Arte>/ChdiJ Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6.Cg-Gt(ROSA)26Sor<tm51(HTT)Arte>/ChdiJ Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6.Cg-Gt(ROSA)26Sor<tm51(HTT)Arte>/ChdiJ Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | B6.Cg-Gt(ROSA)26Sor<tm51(HTT)Arte>/ChdiJ Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.